This study analyzed data of 112 Fitterfly Diabetes program participants with diabetes and hypertension for the effectiveness of digital therapeutics to manage diabetes distress and increase motivation to adapt to a healthy lifestyle. At baseline, all members had high scores of diabetes distress particularly members under 60 years of age had higher total DDS and subcomponent scores. (p< 0.05) Post-program, the median score for overall distress reduced by 25% (p< 0.0001). A substantial reduction in median scores for DDS subscales including emotional burden, physician related, regimen-related, and interpersonal distress was also observed (p< 0.0001). After the program, the median MATCH score showed a significant improvement by 16.7% (p<0.0001). The results suggest that the Fitterfly digital therapeutics program can help improve DDS and motivation score to manage the cardiovascular comorbidities such as hypertension.